viewLexaGene Holdings Inc.

LexaGene hires two salespeople to tackle diagnostic and vet market with new MiQLab analyzers

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has made two key sales hires as they look to begin to roll out their genetic analyzers for rapid pathogen detection called MiQLab.

Regan says they are hiring in the diagnostic and veterinarian space which will be two very key markets for the company. Regan also told Proactive they have exercised 99% of their warrants and brought in a large amount of cash for the treasury.

Quick facts: LexaGene Holdings Inc.

Price: 0.83 CAD

Market: TSX-V
Market Cap: $94.38 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...


LexaGene announces first contract for MiQLab system by major biotech company

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to bring news the company has received a purchase order for the MiQLab system from a multinational biotechnology company that generates billions in annual revenue. Regan says this company was looking...

2 weeks, 1 day ago

2 min read